Search
Patexia Interest Groups

Pharmacokinetics > Nova Content

Scientists reported on the progress of developing ‘backpacking’ bacteria at the 243rd National Meeting & Exposition of the American Chemical Society... Read More »
Universitat Autonoma de Barcelona researchers have developed a new vehicle to release proteins with therapeutic effects. The vehicles are known as ‘bacteria... Read More »
The Center for Nanoscale Science and Technology at the National Institute of Standards and Technology (NIST) is working on creating complex nanostructures by taking... Read More »
Cases in which a newly approved drug is more effective than the cheaper alternatives already available are the exceptions rather than the rule. This is the conclusion ... Read More »
Researchers at the Polytechnic Institute of New York University have developed a new method for creating nanofibers out of proteins. These nanofibers can be used in a ... Read More »
At the turn of the new century, the Institute of Medicine (IOM) released a report titled, “To Err is Human: Building a Safer Health System”.  Citing... Read More »
Researchers at Harvard University have developed a robotic device made from DNA that could potentially seek out specific cell targets within a complex mixture of ... Read More »
Researchers at Brigham and Women’s Hospital in Boston, Mass. have developed a new mechanism of drug release. It uses 3D superhydrophobic materials that make use ... Read More »
Researchers have discovered a brain mechanism that limits the rewarding sensations of cocaine. Recent research with rodents implicated histone deacetylases (HDACs)... Read More »
Researchers at the University of Buffalo (UB) have released results indicating that ORMOSIL (organically modified silica) nanoparticles could be used to deliver... Read More »
Bioengineers at Tufts University School of Engineering have developed a silk-based microneedle able to deliver precise drug amounts over a set time. In addition... Read More »
Researchers at Children’s Hospital Boston have created a new mathematical model that combines multiple forms of widely available data to predict adverse drug... Read More »
McKesson High Volume Solutions will introduce ExpressRx Track this week in New Orleans at the 46th American Society of Health-system Pharmacists Midyear Clinical... Read More »
  BRUSSELS (Reuters) - Belgian biotech firm Ablynx said on Friday that it had regained the rights for its TNF-Alpha targeting nanobodies from Pfizer, which... Read More »
(Reuters) - U.S. health regulators approved on Friday the stroke preventer Xarelto from Bayer AG and Johnson & Johnson for people with a common heart rhythm... Read More »
Traditionally, drugs were discovered by identifying active ingredients in known remedies or through serendipitous discovery, such as penicillin. Currently, drug... Read More »
  By Toni Clarke               (Reuters) - Biogen Idec Inc's said on Wednesday its experimental... Read More »
  Bristol-Myers Squibb is combining its protease inhibitor Reyataz (atazanavir sulfate) with a pharmacoenhancing agent from Gilead Sciences Inc. called... Read More »
  GENEVA (Reuters) - The World Intellectual Property Organization launched a consortium on Wednesday that would allow the public and private sector to... Read More »
  LONDON (Reuters) - Two lung drugs being developed by Novartis and its British partner Vectura face delays in the United States, the... Read More »
Menu
This website is using cookies.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn more
x